Recs

1
Player Avatar cajun1958 (33.54) Submitted: 3/20/2014 3:48:33 PM : Underperform Start Price: $72.98 ENDP Score: +10.12

Lack of anything new can be a problem in pharma when patents expire. ENDO is attempting to grow by acquisition but that rarely works especially when your competitors are after the same thing.

Featured Broker Partners


Advertisement